Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) COO Eric Venker sold 299,384 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $9.91, for a total transaction of $2,966,895.44. Following the sale, the chief operating officer now owns 660,097 shares of the […]
Bank of America initiated coverage on shares of Roivant Sciences (NASDAQ:ROIV – Get Rating) in a research note published on Thursday, The Fly reports. The brokerage issued a neutral rating and a $10.50 price target on the stock. Several other equities research analysts have also recently weighed in on ROIV. HC Wainwright upped their price […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) COO Eric Venker sold 299,384 shares of the stock in a transaction on Friday, June 9th. The stock was sold at an average price of $9.91, for a total transaction of $2,966,895.44. Following the sale, the chief operating officer now directly owns 660,097 shares of the company’s stock, […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) COO Eric Venker sold 299,384 shares of Roivant Sciences stock in a transaction on Friday, June 9th. The stock was sold at an average price of $9.91, for a total transaction of $2,966,895.44. Following the sale, the chief operating officer now directly owns 660,097 shares of the company’s […]
Investment analysts at Bank of America initiated coverage on shares of Roivant Sciences (NASDAQ:ROIV – Get Rating) in a research report issued on Thursday, The Fly reports. The brokerage set a “neutral” rating and a $10.50 price target on the stock. Bank of America‘s target price points to a potential upside of 4.69% from the […]